tradingkey.logo
tradingkey.logo
Search

Revolution Medicines Inc

RVMD
Add to Watchlist
184.000USD
-4.070-2.16%
Close 07-28 16:00ETQuotes delayed by 15 min
36.25BMarket Cap
LossP/E TTM

RVMD Financials

See Revolution Medicines Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Revolution Medicines Inc Earnings Date

Latest Release
May 6, 2026
EPS / Forecast
-2.29/-1.46
Revenue / Forecast
--/2.42M
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-5.95
-66.32%
Analyst Rating
BUY
2026/07/28
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-101.96%-2.29
-67.95%-1.88
-72.18%-1.61
-62.86%-1.31
-61.08%-1.13
2.18%-1.12
5.64%-0.94
12.28%-0.81
1.93%-0.70
-80.33%-1.14
---0.99
---0.92
---0.72
---0.63
---2.47
----
----
----
----
----
Revenue
----
--0.00
--0.00
----
----
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-95.16%742.00K
-100.00%0.00
-58.05%3.82M
-7.44%7.01M
62.05%15.33M
204.81%3.36M
4.81%9.12M
-25.20%7.58M
8.10%9.46M
-91.30%1.10M
-13.24%8.70M
Net Profit
-112.64%-453.82M
-87.54%-364.89M
-95.28%-305.21M
-85.98%-247.79M
-83.97%-213.42M
-20.45%-194.57M
-44.13%-156.29M
-35.54%-133.23M
-70.35%-116.00M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.30M
-18.13%-68.10M
-7.27%-56.51M
-38.51%-73.33M
-38.20%-61.22M
-55.07%-57.65M
-54.01%-52.68M
-94.48%-52.94M
-62.77%-44.30M
Net Margin
----
----
----
----
----
----
----
----
----
-5806.20%-21770.49%
----
---2570.55%
---970.89%
---368.60%
---958.59%
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
0.00%100.00%
----
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
--12.45%
--11.40%
--11.39%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
--0.00
--0.00
----
----
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-95.16%742.00K
-100.00%0.00
-58.05%3.82M
-7.44%7.01M
62.05%15.33M
204.81%3.36M
4.81%9.12M
-25.20%7.58M
8.10%9.46M
-91.30%1.10M
-13.24%8.70M
Operating profit
-84.92%-445.22M
-67.18%-361.63M
-79.42%-315.27M
-68.99%-264.71M
-70.92%-240.76M
-20.18%-216.31M
-42.57%-175.71M
-43.98%-156.64M
-87.42%-140.86M
-191.67%-179.98M
-61.04%-123.25M
-75.23%-108.80M
-29.70%-75.16M
-16.62%-61.71M
-43.96%-76.53M
-39.42%-62.09M
-54.96%-57.95M
-55.26%-52.91M
-92.96%-53.16M
-59.14%-44.53M
Net Profit
-112.64%-453.82M
-87.54%-364.89M
-95.28%-305.21M
-85.98%-247.79M
-83.97%-213.42M
-20.45%-194.57M
-44.13%-156.29M
-35.54%-133.23M
-70.35%-116.00M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.30M
-18.13%-68.10M
-7.27%-56.51M
-38.51%-73.33M
-38.20%-61.22M
-55.07%-57.65M
-54.01%-52.68M
-94.48%-52.94M
-62.77%-44.30M
Current assets
-7.81%1.97B
-10.85%2.08B
25.23%1.98B
33.96%2.18B
23.44%2.13B
23.86%2.33B
91.53%1.58B
76.20%1.62B
87.40%1.73B
184.66%1.88B
22.12%824.47M
90.89%922.09M
72.69%922.75M
11.94%660.18M
8.27%675.11M
-26.92%483.05M
-23.38%534.34M
29.87%589.77M
29.12%623.54M
94.20%661.01M
Total current liabilities
82.60%289.60M
77.18%290.42M
121.55%245.62M
75.19%184.53M
69.22%158.60M
13.95%163.91M
29.60%110.86M
34.94%105.33M
71.54%93.72M
132.08%143.85M
16.75%85.54M
22.85%78.06M
-4.91%54.63M
2.71%61.98M
41.20%73.27M
38.73%63.54M
31.31%57.46M
27.93%60.35M
22.43%51.89M
4.72%45.80M
Total assets
-4.72%2.25B
-7.97%2.35B
27.73%2.25B
34.35%2.43B
23.95%2.37B
24.09%2.56B
79.12%1.76B
68.43%1.81B
77.81%1.91B
153.93%2.06B
19.17%984.23M
69.68%1.07B
57.19%1.07B
10.02%811.93M
12.37%825.91M
-18.25%632.80M
-15.88%682.77M
30.06%737.99M
23.51%734.98M
70.51%774.05M
Total liabilities
162.47%753.82M
146.75%723.21M
233.01%655.02M
197.59%564.20M
57.03%287.20M
24.45%293.10M
34.01%196.69M
32.70%189.59M
51.12%182.90M
85.82%235.51M
1.58%146.77M
6.65%142.87M
-8.16%121.03M
-6.41%126.74M
49.31%144.49M
50.45%133.96M
47.95%131.78M
46.04%135.42M
7.52%96.77M
-4.73%89.04M
Total equity
-27.82%1.50B
-27.98%1.63B
1.95%1.60B
15.23%1.87B
20.44%2.08B
24.04%2.27B
87.03%1.57B
73.91%1.62B
81.21%1.73B
166.52%1.83B
22.90%837.46M
86.60%930.84M
72.82%952.22M
13.71%685.19M
6.77%681.42M
-27.18%498.84M
-23.75%550.99M
26.94%602.57M
26.36%638.20M
90.02%685.01M
Net operating income
-82.15%-354.17M
-98.31%-274.24M
-58.96%-207.31M
-73.02%-221.76M
-21.10%-194.44M
-14.70%-138.29M
-29.77%-130.42M
-90.95%-128.17M
-157.34%-160.56M
-95.12%-120.56M
-94.25%-100.50M
-20.47%-67.12M
-13.11%-62.39M
-57.36%-61.79M
-41.40%-51.74M
-63.48%-55.72M
-48.10%-55.16M
-56.85%-39.27M
-35.41%-36.59M
-70.48%-34.08M
Net investment
1182.29%172.62M
119.06%74.88M
215.74%24.85M
-68.25%34.28M
93.57%-15.95M
-3.29%-392.90M
-127.75%-21.47M
347.90%107.94M
-6305.36%-247.97M
-5254.76%-380.40M
162.66%77.35M
-169.78%-43.54M
-90.92%4.00M
-183.25%-7.10M
-309.05%-123.44M
150.82%62.40M
1806.67%44.02M
-86.44%8.53M
70.11%-30.18M
10.05%-122.78M
Net financing
27216.25%238.74M
-58.15%365.66M
-102.06%-1.59M
3319.28%256.58M
7.90%874.00K
4.10%873.80M
7545.30%77.29M
-88.39%7.50M
-99.75%810.00K
1534.16%839.35M
-99.59%1.01M
4422.74%64.63M
106196.72%324.20M
378.78%51.36M
77747.96%248.34M
64.63%1.43M
-99.89%305.00K
622.42%10.73M
-99.81%319.00K
164.97%868.00K

FAQs

What are the current assets of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its current assets were 2.08B, with a year-on-year change of -10.85.

What are the total assets of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its total assets of Revolution Medicines Inc were 2.35B, with a year-on-year change of -7.97.

What are the total liabilities of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its total liabilities of Revolution Medicines Inc were 723.21M, with a year-on-year change of 146.75.

What is the total equity of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its total equity of Revolution Medicines Inc was 1.63B, with a year-on-year change of -27.98.

What is the net operating income of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its net operating income of Revolution Medicines Inc was -1.18B, with a year-on-year change of -71.48.

What is the net investment of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its net investment of Revolution Medicines Inc was 118.06M, with a year-on-year change of 121.29.

What is the net financing of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its net financing of Revolution Medicines Inc was 621.52M, with a year-on-year change of -35.22.

What is the Earnings Per Share (EPS) of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -5.95, with a year-on-year change of -66.32.

What is the net income of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its net income was -1.13B, with a year-on-year change of -88.52.

What is the Return on Equity (ROE) of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its Return on Equity (ROE) was -58.07, with a year-on-year change of -97.95.

What is the Return on Assets (ROA) of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its Return on Assets (ROA) was -46.06, with a year-on-year change of -77.29.

What is the operating profit of Revolution Medicines Inc?

According to Revolution Medicines Inc's FY2025 earnings report, its operating profit was -1.18B, with a year-on-year change of -71.48.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.